Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02156336

Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)

Diabetic Peripheral Neuropathic Pain Clinical Trial

Official title:
A Double-Blind, Placebo-Controlled, Randomized, Parallel Assignment, U.S. Study of Ranolazine for the Treatment of Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

Clinical Trial Summary

The purpose of this trial is to determine if patients suffering from diabetic peripheral neuropathic pain treated with ranolazine will have a greater reduction in pain compared to placebo.

Hypothesis: From the prior clinical observations, and analgesic efficacy in the preclinical animal model of neuropathic pain, the investigators hypothesize that subjects randomized to ranolazine will show a greater reduction in diabetic neuropathic pain compared to placebo.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02156336
Study type Interventional
Source Horizons International Peripheral Group
Contact
Status Terminated
Phase Phase 4
Start date May 2014
Completion date February 8, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT04094662 - A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain Phase 3
Not yet recruiting NCT06054087 - Effectiveness of Electroacupuncture in the Treatment of Diabetic Peripheral Neuropathy N/A
Not yet recruiting NCT05292066 - Efficacy of Pregabalin Vs Duloxetine in Diabetic Peripheral Neuropathic Pain at Variable Dose Early Phase 1
Completed NCT04688671 - Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain Phase 2
Recruiting NCT06203002 - A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) Phase 2
Completed NCT05620576 - A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05) Phase 2
Completed NCT04146896 - Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN) Phase 2
Recruiting NCT05521737 - Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy N/A
Terminated NCT04707157 - Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain Phase 2
Recruiting NCT06122012 - To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China N/A
Recruiting NCT06221241 - Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain Phase 2
Completed NCT01314222 - Diabetic Peripheral Neuropathic Pain (DPNP) Phase 2
Completed NCT00829387 - Cognitive Behavioral Therapy for Diabetic Neuropathic Pain N/A
Not yet recruiting NCT05766969 - Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA Phase 1/Phase 2
Completed NCT05349357 - Slider Versus Tensioner Neural Mobilization in Diabetic Peripheral Neuropathy N/A
Completed NCT03909841 - Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition
Completed NCT04476108 - Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain Phase 2
Not yet recruiting NCT04953221 - The Effect of YJ001 on Diabetic Peripheral Neuropathic Pain.
Completed NCT05177094 - Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain Phase 2
Completed NCT02318706 - DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain Phase 3